Related Experiment Video

Updated: May 13, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Mitochondrial epilepsy in pediatric and adult patients

J Finsterer1, S Zarrouk Mahjoub

  • 1Krankenanstalt Rudolfstiftung, Vienna, Austria. fifigs1@yahoo.de

Acta Neurologica Scandinavica
|March 14, 2013
PubMed

Insights

Mitochondrial epilepsy differs significantly between children and adults. Pediatric cases often involve nuclear DNA mutations and syndromic epilepsy, while adult cases are more frequently non-syndromic with mitochondrial DNA mutations.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Mitochondrial disorders (MIDs) can cause epilepsy, but differences between pediatric and adult presentations are not well-documented.
  • Understanding these distinctions is crucial for accurate diagnosis and management of mitochondrial epilepsy.

Purpose of the Study:

  • To review and highlight the key differences in epilepsy between pediatric and adult patients with mitochondrial disorders.
  • To compare seizure types, frequency, underlying genetic causes, and phenotypic presentations.

Main Methods:

  • A comprehensive literature search was conducted using PubMed.
  • Keywords included 'mitochondrial', 'epilepsy', 'seizures', 'adult', 'pediatric', and various MID acronyms.

Main Results:

  • Mitochondrial epilepsy is more frequent in pediatric patients, often linked to nuclear DNA mutations and syndromic phenotypes.
  • Adult mitochondrial epilepsy is more commonly associated with mitochondrial DNA mutations and non-syndromic phenotypes.
  • Focal seizures predominate in pediatric cases, whereas generalized seizures are more frequent in adults. Electro-clinical syndromes are more common in pediatric MIDs.

Conclusions:

  • Significant differences exist in the onset, frequency, seizure types, genetic basis, and clinical presentation of epilepsy between pediatric and adult mitochondrial disorders.
  • Differentiating between early-onset and late-onset forms of mitochondrial epilepsy is essential for optimizing patient management.

Keywords:
antiepileptic drugscentral nervous system involvementelectroencephalographyepilepsymitochondrial disorderseizure

More Related Videos

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes08:56

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Related Concept Videos

Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...